
AstraZeneca PLC AZN
Annual report 2025
added 02-28-2026
AstraZeneca PLC Operating Cycle 2011-2026 | AZN
Annual Operating Cycle AstraZeneca PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 206 | 168 | 122 | 132 | 139 | 112 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 206 | 112 | 147 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Axsome Therapeutics
AXSM
|
273 | $ 163.89 | - | $ 8.15 B | ||
|
BridgeBio Pharma
BBIO
|
285 | $ 64.28 | -3.31 % | $ 12.3 B | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
BioCardia
BCDA
|
101 | $ 1.37 | 5.81 % | $ 29 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
BioMarin Pharmaceutical
BMRN
|
733 | $ 59.8 | -3.13 % | $ 11.5 B | ||
|
Bristol-Myers Squibb Company
BMY
|
153 | $ 62.08 | -0.46 % | $ 126 B | ||
|
Benitec Biopharma
BNTC
|
141 | $ 10.93 | 0.23 % | $ 450 M | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
BioXcel Therapeutics
BTAI
|
244 | $ 1.63 | -2.4 % | $ 4.13 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 11.67 | -3.47 % | $ 768 M | ||
|
C4 Therapeutics
CCCC
|
27.9 | $ 3.06 | 13.3 % | $ 254 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Codexis
CDXS
|
50.2 | $ 0.99 | -2.04 % | $ 72.7 M | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M |